Medical devices, healthcare technology and the business of care
510(k) clearance · K252288

TECAR Therapy Device (TC2000, TC2001)

Shenzhen Dongdixin Technology Co., Ltd. · Decision date Oct 13, 2026

MEDTECHLEDGER EXPLANATIONK252288

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for K252288, the TECAR Therapy Device (TC2000, TC2001), on 2026-10-13, with the application received 07/23/2025. The applicant is Shenzhen Dongdixin Technology Co., Ltd. of Shenzhen, China. The submission is a Traditional 510(k) under regulation 878.4400, product code PBX, in the General & Plastic Surgery panel and specialty; the classification name shown is Massager, Vacuum, Radio Frequency Induced Heat. SESE means 510(k) clearance, not PMA approval.

The record shows no third-party review, no combination product status and no authorized Predetermined Change Control Plan. The listed summary is a Statement rather than a Summary. The source does not describe the device's components, technical specifications, intended use, indications, or the predicate device and comparison basis, so the scope of the clearance cannot be characterized beyond the fields above. No clinical or performance data are available in the provided material.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General, Plastic Surgery
Decision date
Oct 13, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K252288
Regulatory pathway
510(k) premarket notification
Product code
PBX
Decision code
SESE
Decision date
Oct 13, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Massager, Vacuum, Radio Frequency Induced Heat.

Product code
PBX
FDA device class
2

FDA decision timeline

  1. K252288 received

    Application receipt date recorded by FDA.

  2. K252288 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code PBX

Product / regulatory recordCompanyPathwayDecision dateSource
Bh Group Us, LLC510(k) clearanceSep 22, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Shenzhen Dongdixin Technology Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Shenzhen

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records